Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Trials. 2024 Jan 13;25(1):49. doi: 10.1186/s13063-024-07902-7.
The management of small gastric submucosal tumors (SMTs) originating from the muscularis propria layer (SMT-MPs) remains a subject of debate. Endoscopic submucosal dissection (ESD) is currently considered the optimal treatment for resection. However, high expenses, complex procedures, and the risk of complications have limited its application. Our previously proposed novel operation, precutting endoscopic band ligation (precutting EBL), has been demonstrated in a long-term, single-arm study to be an effective and safe technique for removing small gastric SMTs. However, the absence of a pathological examination and the potential for delayed perforation have raised concerns. Thus, we modified the precutting EBL by adding endoscopic resection to the snare after ligation and closure, yielding the precutting endoscopic band ligation-assisted resection (precutting EBLR). Moreover, the initial pilot study confirmed the safety and efficacy of the proposed approach and we planned a randomized controlled trial (RCT) to further validate its clinical feasibility.
This was a prospective, single-center, open-label, parallel group, and randomized controlled trial. Approximately 40 patients with SMT-MPs will be included in this trial. The patients included were allocated to two groups: ESD and precutting EBLR. The basic clinical data of the patients were collected in detail. To better quantify the difference between ESD and precutting EBLR, the primary outcome was set as the operation duration. The secondary outcomes included total operation cost and hospitalization, intraoperative adverse events, and postoperative recurrence. The primary outcome was tested for superiority, while the secondary outcomes were tested for noninferiority. SPSS is commonly used for statistical analysis.
This study was designed to validate the feasibility of a novel operation for removing gastric SMT-MPs. To intuitively assess this phenomenon, the operation durations of precutting EBLR and ESD were compared, and other outcomes were also recorded comprehensively.
Chinese Clinical Trial Registry ChiCTR2200065473 . Registered on November 5, 2022.
起源于固有肌层的小胃黏膜下肿瘤(SMTs)的治疗管理仍然存在争议。内镜黏膜下剥离术(ESD)目前被认为是切除的最佳治疗方法。然而,高费用、复杂的程序和并发症的风险限制了其应用。我们之前提出的新手术,预切开内镜套扎(precutting EBL),在一项长期的单臂研究中已被证明是一种有效和安全的技术,用于切除小的胃 SMTs。然而,由于缺乏病理检查和潜在的延迟穿孔,人们对此表示担忧。因此,我们通过在结扎和闭合后在内镜下切除圈套器来改进预切开 EBL,得到预切开内镜套扎辅助切除(precutting EBLR)。此外,初步的试点研究证实了该方法的安全性和有效性,我们计划进行一项随机对照试验(RCT)来进一步验证其临床可行性。
这是一项前瞻性、单中心、开放标签、平行组、随机对照试验。大约 40 名 SMT-MPs 患者将参与这项试验。将患者分为 ESD 和 precutting EBLR 两组。详细收集患者的基本临床资料。为了更好地量化 ESD 和 precutting EBLR 之间的差异,将手术时间设定为主要结局。次要结局包括总手术费用和住院时间、术中不良事件和术后复发。主要结局测试为优效性,次要结局测试为非劣效性。SPSS 通常用于统计分析。
本研究旨在验证一种新的胃 SMT-MPs 切除手术的可行性。为了直观地评估这一现象,我们比较了 precutting EBLR 和 ESD 的手术时间,并综合记录了其他结果。
中国临床试验注册中心 ChiCTR2200065473 。注册于 2022 年 11 月 5 日。